Dakpha Holding

Danesh Kimia Pharmed Co. was established on 2011 by industrial and university researchers in order to invest on the production of new pharmaceutical molecules and their ready to use pharmaceutical dosage forms. The company is known as the pioneer generic producer for new entities and ready to use pharmaceutical formulations made by research and production units. It has created a production line for anticancer active ingredients in Baran Chemical and Pharmaceutical Co., molecules in low quantity with high value such as Fingolimod, Nitisinone, Bosentan, etc. in Danesh Pharmaceutical Development Co. and also producing Opioid molecules and its new derivatives in Alborz Pharmed Co. Most of the produced molecules in subset groups of Danesh Kimia Pharmed Co. are among new pharmaceutical molecules and also the company is known as their first generic producer in the world.